Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q3 2023 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to the Allogene Therapeutics Third Quarter 2023 Conference Call.
Source: insidermonkey.com
Page 22 - Michael Yee News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Michael Yee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Michael Yee Today - Breaking & Trending Today
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Q3 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Cerevel Therapeutics Third Quarter Financial Results Conference call. At this time, all participants are in listen-only mode.
Source: insidermonkey.com
Analysts predict Moderna to meet COVID-19 forecast for 2023
Moderna's shares have fallen by some 22% since its larger rival's warning
Source: geo.tv
Moderna revenue tops expectations, expects to return to sales growth in 2025
Moderna on Thursday said it expected 2023 revenue of at least $6 billion, a decline reflecting weaker demand for COVID-19 vaccines this year, but that it would return to sales growth in 2025 and...
Source: marketscreener.com
Moderna tempers 2023 COVID vaccine sales forecast
(Reuters) -Moderna on Thursday said it expected 2023 revenue of at least $6 billion, tempering its forecast to reflect weaker demand for COVID-19 vaccines, but added it would return to sales growth in 2025 and break even the following year. The company reported third-quarter sales of $1.8 billion, topping analysts' estimates of $1.32 billion, according to LSEG data. Moderna's COVID-19 vaccine is its lone marketed product.
Source: yahoo.com